Copyright © 2001 by the European Society of Cardiology.
Optimal risk factors in the population: prognosis, prevalence, and secular trends. Data from Göteborg population studies
Section of Preventive Cardiology, Sahlgrenska University Hospital/Östra, Göteborg, Sweden
revised March 17, 2000; accepted March 21, 2000
Abstract
Aims To assess the prognosis and prevalence of optimal risk factors in the population.
Methods and Results Data from several Göteborg population studies were used. Optimal risk factors were defined as serum cholesterol <5mmol.l1, blood pressure <140/90 without treatment and being a non-smoker. In a 20-year follow-up of 7130 men aged 47 to 55 at baseline a group of 117 men who were optimal with respect to cholesterol, blood pressure and smoking were identified. In this group there was only one death from coronary disease, corresponding to 0·4 deaths per 1000 years, whereas the overall risk of coronary death in the study was 4·8 per 1000 years. Among men and women aged 25 to 34 in the Göteborg MONICA study 1995, less than half were optimal on all three scores, and in men and women aged 55 to 64, only 7% and 6%, respectively, were optimal. If body mass index below 25 was included only 34% and 37%, respectively, of men and women aged 25 to 34 were optimal, and 11% and 22% among men and women aged 35 to 44. In an analysis of secular trends over 30 years in four successive cohorts of men aged 50 the prevalence of optimal risk factors with respect to cholesterol, blood pressure and smoking increased from 1963 to 1993 but was still only 11% in 1993.
Conclusions As expected, optimal risk factors with respect to serum cholesterol, blood pressure and smoking confers a very low risk of coronary death. However, the prevalence of optimal risk factor status in the Swedish population is still low.
Key Words: Coronary disease, risk factors, smoking, cholesterol, blood pressure, population study
f1 Correspondence: Annika Rosengren, MD, professor, Department of Medicine, Sahlgrenska University Hospital/Östra, SE-416 85 Göteborg, Sweden.
![]()
CiteULike
Connotea
Del.icio.us What's this?
This article has been cited by other articles:
![]() |
P. Ostlin, K. Klerdal, and N. Hammar Time trends in incidence of myocardial infarction in male and female dominated occupations in Stockholm, Sweden Scand J Public Health, July 1, 2008; 36(5): 546 - 554. [Abstract] [PDF] |
||||
![]() |
T. A. Pearson The Prevention Of Cardiovascular Disease: Have We Really Made Progress? Health Aff., January 1, 2007; 26(1): 49 - 60. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. B. Lynch, K. Liu, C. I. Kiefe, and P. Greenland Cardiovascular Disease Risk Factor Knowledge in Young Adults and 10-year Change in Risk Factors: The Coronary Artery Risk Development in Young Adults (CARDIA) Study Am. J. Epidemiol., December 15, 2006; 164(12): 1171 - 1179. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Farnkvist and L. Weinehall Assessment of intervention intensity: Experiences from a small-scale Swedish cardiovascular disease prevention programme Scand J Public Health, May 1, 2006; 34(3): 279 - 286. [Abstract] [PDF] |
||||
![]() |
P. McCarron and G. Davey Smith Commentary: Incubation of coronary heart disease--recent developments Int. J. Epidemiol., April 1, 2005; 34(2): 248 - 250. [Full Text] [PDF] |
||||
![]() |
M. L. Daviglus, J. Stamler, A. Pirzada, L. L. Yan, D. B. Garside, K. Liu, R. Wang, A. R. Dyer, D. M. Lloyd-Jones, and P. Greenland Favorable Cardiovascular Risk Profile in Young Women and Long-term Risk of Cardiovascular and All-Cause Mortality JAMA, October 6, 2004; 292(13): 1588 - 1592. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. A. Pearson, T. L. Bazzarre, S. R. Daniels, J. M. Fair, S. P. Fortmann, B. A. Franklin, L. B. Goldstein, Y. Hong, G. A. Mensah, J. F. Sallis Jr, et al. American Heart Association Guide for Improving Cardiovascular Health at the Community Level: A Statement for Public Health Practitioners, Healthcare Providers, and Health Policy Makers From the American Heart Association Expert Panel on Population and Prevention Science Circulation, February 4, 2003; 107(4): 645 - 651. [Full Text] [PDF] |
||||
![]() |
E. J. Benjamin, S. C. Smith Jr, R. S. Cooper, M. N. Hill, and R. V. Luepker Task Force #1--magnitude of the prevention problem: opportunities and challenges J. Am. Coll. Cardiol., August 21, 2002; 40(4): 588 - 603. [Full Text] [PDF] |
||||
![]() |
T. A. Pearson, S. N. Blair, S. R. Daniels, R. H. Eckel, J. M. Fair, S. P. Fortmann, B. A. Franklin, L. B. Goldstein, P. Greenland, S. M. Grundy, et al. AHA Guidelines for Primary Prevention of Cardiovascular Disease and Stroke: 2002 Update: Consensus Panel Guide to Comprehensive Risk Reduction for Adult Patients Without Coronary or Other Atherosclerotic Vascular Diseases Circulation, July 16, 2002; 106(3): 388 - 391. [Full Text] [PDF] |
||||
![]() |
W.B. Kannel Quest for an optimal population cardiovascular risk factor burden Eur. Heart J., January 2, 2001; 22(2): 105 - 107. [PDF] |
||||







